Tirzepatide in Obstructive Sleep Apnea: A Bibliometric Analysis
Research Article
DOI:
https://doi.org/10.5281/zenodo.20834795Keywords:
Tirzepatide, Obstructive Sleep Apnea, Bibliometrics, Scientific Mapping, Incretin-Based TherapiesAbstract
Introduction: Obstructive sleep apnea (OSA) is a highly prevalent sleep-related breathing disorder closely associated with obesity and cardiometabolic dysfunction. Recent advances in incretin-based therapies, particularly tirzepatide, have generated increasing interest in metabolically targeted approaches for OSA management.
Objective: This study aimed to comprehensively map and analyze global research trends on tirzepatide in OSA, with a focus on publication output, citation patterns, geographic and institutional contributions, collaboration networks, and thematic structures.
Methods: A comprehensive bibliometric analysis was conducted using the Web of Science (WoS; Clarivate Analytics) database. The literature was searched from 2022, corresponding to the initial clinical introduction of tirzepatide, through September 18, 2025. Bibliometric indicators were evaluated using performance analysis, network analysis, and multiple correspondence analysis to assess research productivity, citation dynamics, international collaboration, and conceptual structures.
Results: A total of 39 publications with a total of 363 citations were identified, with a marked increase in publication output and citation activity after 2023. The United States and Australia were the leading contributors, and scientific production was concentrated among a limited number of authors and institutions. Keyword co-occurrence analysis revealed three principal thematic clusters: pharmacological, cardiometabolic, and respiratory domains. Citation analysis demonstrated that a small number of high-impact clinical trials accounted for the majority of citations, whereas many recent publications had not yet accumulated citations, reflecting the emerging nature of the field.
Conclusion: This study maps global research on tirzepatide in OSA, demonstrating increasing integration of cardiometabolic and respiratory research and providing a framework for future clinical research and interdisciplinary collaboration.
References
Malhotra A, White DP. Obstructive sleep apnoea. Lancet. 2002;360(9328):237-245. doi:10.1016/S0140-6736(02)09464-3
Somers VK, White DP, Amin R, et al. Sleep apnea and cardiovascular disease: an American Heart Association scientific statement. Circulation. 2008;118(10):1080-1111. doi:10.1161/CIRCULATIONAHA.107.189420
Reutrakul S, Mokhlesi B. Obstructive sleep apnea and diabetes: a state-of-the-art review. Chest. 2017;152(5):1070-1086. doi:10.1016/j.chest.2017.05.009
Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. Am J Respir Crit Care Med. 2000;162(4):1378-1384. doi:10.1164/ajrccm.162.4.9905007
Frías JP, Davies MJ, Rosenstock J, et al. Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. N Engl J Med. 2021;385(6):503-515. doi:10.1056/NEJMoa2107519
Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387(3):205-216. doi:10.1056/NEJMoa2206038
Blackman A, Foster GD, Zammit G, et al. Effect of liraglutide 3.0 mg in individuals with obesity and moderate or severe obstructive sleep apnea: the SCALE Sleep Apnea randomized clinical trial. Int J Obes (Lond). 2016;40(8):1310-1319. doi:10.1038/ijo.2016.52
Malhotra A, Grunstein RR, Fietze I, et al. Tirzepatide for the treatment of obstructive sleep apnea and obesity. N Engl J Med. 2024;391(13):1193-1205. doi:10.1056/NEJMoa2404881
Aria M, Cuccurullo C. Bibliometrix: an R-tool for comprehensive science mapping analysis. J Informetr. 2017;11(4):959-975. doi:10.1016/j.joi.2017.08.007
Donthu N, Kumar S, Mukherjee D, Pandey N, Lim WM. How to conduct a bibliometric analysis: an overview and guidelines. J Bus Res. 2021;133:285-296. doi:10.1016/j.jbusres.2021.04.070
Wang D, Song C, Barabási AL. Quantifying long-term scientific impact. Science. 2013;342(6154):127-132. doi:10.1126/science.1237825
Wagner CS, Park HW, Leydesdorff L. The continuing growth of global cooperation networks in research: a conundrum for national governments. PLoS One. 2015;10(7):e0131816. doi:10.1371/journal.pone.0131816
Kokol P, Blažun Vošner H, Završnik J. Application of bibliometrics in medicine: a historical bibliometric analysis. Health Info Libr J. 2021;38(2):125–138.
Benjafield AV, Ayas NT, Eastwood PR, et al. Estimation of the global prevalence and burden of obstructive sleep apnoea. Lancet Respir Med. 2019;7(8):687-698. doi:10.1016/S2213-2600(19)30198-5
BaHammam AS. Personalizing Obstructive Sleep Apnea Therapy Using Machine Learning: Insights from the ISAACC Trial. Ann Am Thorac Soc. 2024;21(7):1005-1006. doi:10.1513/AnnalsATS.202403-308ED
Zinchuk AV, Jeon S, Koo BB, et al. Polysomnographic phenotypes and their cardiovascular implications in obstructive sleep apnea. Am J Respir Crit Care Med. 2021;203(3):372-385. doi:10.1164/rccm.202005-1859OC
Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med. 2000;342(25):1887-1892. doi:10.1056/NEJM200006223422507
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Acta Medica Ruha
This work is licensed under a Creative Commons Attribution 4.0 International License.
